×

Rxstrategies, Inc. Appoints National Sales Manager - West Region

BOCA RATON, Florida, June 3, 2015 (GLOBE NEWSWIRE) -- RxStrategies, Inc. is pleased to announce the appointment of Jon Braff to the new position of National Sales Manager - West Region. He joins the RxStrategies' senior leadership team and has responsibility for sales and delivery of customized 340B pharmacy administration and split billing solutions to providers located in the West Region.

"I am very pleased to welcome Jon to the RxStrategies' leadership team," said Fenton Markevich, Chief Executive Officer for RxStrategies. "We look forward to incorporating Jon's deep 340B market and product expertise and knowledge for the benefit of our existing and future clients. We believe that Jon will be a strong addition and work well with our current market facing team."

Jon joins RxStrategies with acknowledged industry leadership and an extensive background in market facing roles to the 340B pharmacy administration market. Jon is a graduate of St. Mary's College of California.

"RxStrategies has a strong reputation in the West Region marketplace with both a unique and transparent processing solution, and a proprietary split billing solution for this complex market," said Braff. "I am excited to join a growing industry leader and bring value to clients and prospects by using a consultative approach. I look forward to continuing that tradition by providing 340B guidance and insight to our current and future clients."

About RxStrategies, Inc.

Established in 2003 and headquartered in Boca Raton, Florida, RxStrategies, Inc. provides accountability, transparency and value-based solutions for the Federal 340B Drug Pricing Programs. As a full-service 340B Drug Pricing Program services organization, RxStrategies provides a diverse range of services to all "Qualified Entities" and the in-house and/or contract pharmacies, including 340B administration, split billing, orphan drug, and audit services. RxStrategies' "real-time" comprehensive solutions are designed to meet the challenges of regulatory compliance, patient eligibility, pharmacy replenishment, program tracking and reporting of the Federal 340B Drug Pricing Program. To learn more, please visit www.340Bplus.com.

###

CONTACT: Cheryl Musial, Media Relations, Mopdog, Inc. cheryl@mopdog.com 678-737-7325

Source:RxStrategies, Inc.